New York City Public Schools students can obtain work experience in health care through a partnership with Memorial Sloan ...
Eligibility for treatment with the latest cancer drugs is often determined by genetic mutations in tumors, criteria that ...
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...
Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...
A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how ...
An expanding body of research indicates that aerobic exercise and strength-training can improve the chances of survival.
In an intriguing revelation from recent research, mitochondria have been shown not only to power the cell but also to ...
The age of testing for colorectal cancer has been pushed from 50 to 45, and it is even earlier for at-risk patients because of the rise in the number of young adults being diagnosed with the disease.
Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...
Oncologist David Chung is taking on Northwell Health's newly established role of director of clinical research at its cancer ...
Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.
Testing BRCA2 has long been a staple of hereditary cancer testing, as pathogenic variants in the gene are associated with cancers of the breast, ovary, prostate, and pancreas. 2-5 Despite the ...